Source · study

Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial

Primary source

Publisher:: British Journal of Dermatology (Taieb, Ortonne, Ruzicka, Roszkiewicz, Berth-Jones & Peirone)
Source type:: Journal · study
Last checked:: 2026-10-26
URL:: https://doi.org/10.1111/bjd.13408

Pages that cite it

Evidence: In moderate-to-severe papulopustular rosacea, once-daily ivermectin 1% cream reduced inflammatory lesion counts by 83.0% from baseline at 16 weeks versus 73.7% for twice-daily metronidazole 0.75% cream (P<0.001, 962 participants), and more subjects reached 'clear' or 'almost clear' on the investigator's global assessment (84.9% vs 75.4%, P<0.001).